ICE-HBV Symposium: RNA-Targeting Therapies for Sustained HBV Suppression September 23, 2023 in Kobe, Japan (Hybrid)
Dear Scientists, Clinicians, and Industry Representatives,
You are cordially invited to the ICE-HBV Symposium: RNA-Targeting Therapies for Sustained HBV Suppression, organized in conjunction with the International HBV Meeting. Mark your calendar for this exceptional event taking place on September 23, 2023, from 9:00 AM to 12:00 PM Japan Standard Time.
The ICE-HBV Symposium provides a unique platform for scientists, clinicians, and industry representatives to come together and discuss the challenges surrounding RNA-targeting therapies for sustained HBV suppression. Chaired by leading experts in the field, Adam Gehring from Canada and Maura Dandri from Germany, this event promises invaluable insights and groundbreaking discussions.
During the symposium, we will delve into the currently known mechanisms and potential determinants of sustained HBV control after RNA-targeting therapies. Our objectives include exploring the underlying mechanisms of persistent HBV control, discussing immune restoration prospects following antigen reduction, exploring strategies for targeting hepatitis delta virus (HDV) and evaluating the most promising combination therapies. This interactive event will foster knowledge sharing, identify gaps in our understanding, and propose a way forward in HBV cure research.
To register for the ICE-HBV Symposium ONLY, please visit the following link: REGISTRATION
To view the program, please visit the following link:
2023 KOBE ICE-HBV SYMPOSIUM PROGRAM
Please note that the cost to attend the symposium is $40 USD + tax.
Join us at the ICE-HBV Symposium and be part of this transformative event that will shape the future of HBV cure.
We look forward to your active participation and valuable contributions.
Best regards,
ICE-HBV Secretariat,
info@ice-hbv.org